Osteopathic Manipulative Treatment in pregnant wome
- Conditions
- Pregnancy-induced hypertensionC12.050.703
- Registration Number
- RBR-9q7kvg
- Lead Sponsor
- Instituto Fernandes Figueira- IFF/Fiocruz
- Brief Summary
The prospective study on hemodynamics aimed to evaluate the maternal-fetal hemodynamic effects after osteopathic manipulative treatment by measuring vital signs and Doppler velocimetry in pregnant women in the third trimester. The materials and methods are a prospective study with pregnant women undergoing outpatient care admitted to an infirmary at the Instituto Fernandes Figueira/Fiocruz between August 2021 and August 2022 during the COVID 19 pandemic. The study population consisted of fifty-one pregnant women between twenty-eight and forty weeks of gestation, over eighteen years of age, allocated to a single group. Pregnancies with multiple fetuses, malformations, premature rupture of the membrane, and active labor were excluded. The procedures assessed maternal-fetal hemodynamics through three consecutive ultrasound measurements with Doppler velocimetry and three maternal vital signs measured by an electronic blood pressure monitor. The results showed that most vital signs changed after osteopathic treatment. However, only systolic blood pressure (109,92±14.42 to 110,71±12,8, p=0,033), diastolic blood pressure (79,8±11,54 to 77,57±9.44, p =0,018), and heart rate (87,59±11,93 to 81,12±10,26, p=0,000) in the sitting position, systolic blood pressure (110,75±13.26 to 108,59±13, 07; p=0,034) in the supine position and the heart rate (83,22±11,29 to 80,39±11,0; p=0,013) in the left lateral decubitus position reached statistical significance. Oximetry measurements (98,55±0,64 to 98,67±0,68; p=0,098) remained stable in the three positions. All artery values remained stable after treatment; no statistically significant differences were recorded in artery results. The conclusion was that responses to osteopathic treatment in women in the third trimester of pregnancy did not affect uteroplacental and fetal placental circulation. However, some maternal vital signs had statistically significant results, with a decrease in blood pressure and diastolic frequency and an increase in systolic blood pressure in the sitting position, a reduction in heart rate in the left lateral decubitus position and systolic blood pressure in the supine position. All observed results were maintained within the usual parameters. The study responses attest to the safety of using osteopathic manipulative treatment for the fetus and pregnant women with comorbidities. This was according to the study. A prospective observational. During pregnancy, a woman's various changes can affect her health status. Manual therapies are necessary aids because they do not use medications. This study aimed to evaluate the influence of osteopathic manipulative treatment on the intensity of lumbar and pelvic muscle pain and changes in quality of life. This prospective study included women over eighteen years of age and between twenty-seven and forty-one weeks of pregnancy, excluding women with fetal malformations, multiple fetuses, premature rupture of membranes, and labor. Forty-six pregnant women were selected and divided into two groups of three and four visits. Statistically significant improvements were observed in maximum (7,54±1,47 vs 3,815 ±1,73, p 0,01) and minimum low back pain intensity (5,67± 2,03 vs 3,111±1,67, p 0,01), maximum pelvic pain (6,54±2.22 vs 2,77±1,64, p = 0,01) and minimal (5,615± 2,21 vs 2,615 ±1,66, p = 0,01). Both groups improved quality of life indices, with improvements achieved by the four-visit group being statistically significant. Osteopathic treatment was effective in reducing the intensity of low back and pelvic pain and improving the quality of life of pregnant women in the third trimester
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Data analysis completed
- Sex
- Female
- Target Recruitment
- Not specified
Normotensive and hypertensive pregnant women in the third trimester; over 18 years old; accepted at IFF/Fiocruz to carry out prenatal care in the outpatient clinic and in the pregnancy ward between July 2021 and September 2022
Pregnant women with bleeding; with clear signs of premature birth (contraction, dilation); with twin pregnancy; with fetal malformation; signs of eclampsia (based on blood and urine tests and BP measurement); and HELLP syndrome
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method